Business News

Watson buying generic drugmaker Actavis for $5.6B

Watson buying generic drugmaker Actavis for $5.6B

PARSIPPANY, N.J. -- Watson Pharmaceuticals Inc. is buying another generic drugmaker, Switzerland's Actavis Group, for about $5.6 billion in a move that will make Watson in the world's...

Posted: 04/25/12 at 6:15 pm EDT

Latest Video